Company: IMNN
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001641172-25-013088
Chunk: 39

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 39
---
 Stacy R. Lindborg           |
|         | Stacy                       
 R. Lindborg, Ph.D.          |
|         | President                   
 and Chief Executive Officer |

<div align='center'>POWER OF ATTORNEY</div>

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stacy Lindborg, David Gaiero, and Susan Eylward and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution and resubstitution, for him or her and in his or her name, place or stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, and (iv) take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

| Name                 
 /s/                  
 Stacy R. Lindborg    |     | Position                         
 President,                       
 Chief Executive Officer and      |     | Date     
 May      
 30, 2025 |
|:---------------------|:----|:---------------------------------|:----|:---------|
| Stacy                
 R. Lindborg, Ph.D.   |     | Director                         
 (Principal Executive Officer)    |     |          |
| /s/                  
 David Gaiero         |     | Chief                            
 Financial Officer                |     | May      
 30, 2025 |
| David                
 Gaiero               |     | -Principal                       
 Financial and Accounting Officer |     |          |
| /s/                  
 Michael H. Tard